Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of Toronto

$27,000.00

Investigating the relationship between eosinophilia and the use of biological therapies in pediatric patients with systemic juvenile idiopathic arthritis

FY 2025-26

Summary
Systemic juvenile idiopathic arthritis (JIA) is a condition occurring in children where they can develop inflammation affecting the joints and other organ systems. Several decades ago, prior to the advent of biologic medications, this condition had a poor prognosis with a significant risk of joint damage, functional limitations, and even mortality resulting from poorly controlled inflammation. Since biologic therapies began 20 years ago, the prognosis of this condition has significantly improved, and poor outcomes exist only in the minority of patients. Unfortunately, over the last decade there have been increasing reports of a possible reaction occurring in patients with systemic JIA who are treated with biologic medications. In rare cases, this reaction has been linked with the development of lung inflammation. Some researchers have labelled this reaction as a type of drug reaction with a common feature being high eosinophils, a type of blood cell often associated with allergies. This is a highly debated area among researchers in the field, with some believing that the reaction observed is not related to a drug reaction, and the high eosinophil levels can also be disease-related and observed when systemic JIA is active. Our study aims to better understand the context of high eosinophil counts in this disease. We will do this by comparing groups of patients with systemic JIA, one group treated with biologic therapy and one without, to see if there is any difference in development of high eosinophil counts. If we observe high eosinophil counts also frequently occurring in patients not treated with biologics, then this adds evidence against the theory of a drug reaction. We hope that our results will help guide treatment decisions.
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
573056
Name
Quilty Rebecca
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the relationship between eosinophilia and the use of biological therapies in pediatric patients with systemic juvenile idiopathic arthritis
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Eosinophilia; Pediatric; Systemic Juvenile Idiopathic Arthritis
Abstract
Systemic juvenile idiopathic arthritis (JIA) is a condition occurring in children where they can develop inflammation affecting the joints and other organ systems. Several decades ago, prior to the advent of biologic medications, this condition had a poor prognosis with a significant risk of joint damage, functional limitations, and even mortality resulting from poorly controlled inflammation. Since biologic therapies began 20 years ago, the prognosis of this condition has significantly improved, and poor outcomes exist only in the minority of patients. Unfortunately, over the last decade there have been increasing reports of a possible reaction occurring in patients with systemic JIA who are treated with biologic medications. In rare cases, this reaction has been linked with the development of lung inflammation. Some researchers have labelled this reaction as a type of drug reaction with a common feature being high eosinophils, a type of blood cell often associated with allergies. This is a highly debated area among researchers in the field, with some believing that the reaction observed is not related to a drug reaction, and the high eosinophil levels can also be disease-related and observed when systemic JIA is active. Our study aims to better understand the context of high eosinophil counts in this disease. We will do this by comparing groups of patients with systemic JIA, one group treated with biologic therapy and one without, to see if there is any difference in development of high eosinophil counts. If we observe high eosinophil counts also frequently occurring in patients not treated with biologics, then this adds evidence against the theory of a drug reaction. We hope that our results will help guide treatment decisions.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Quilty, Rebecca
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~